Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C014211 |
2,3,7,8-tetrachlorodibenzofuran |
2,3,7,8-tetrachlorodibenzofuran affects the expression of NOTCH1 mRNA | affects expression | 18343893
|
C028145 |
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine |
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine results in decreased activity of NOTCH1 protein | decreases activity | 20348013
|
C028145 |
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine |
[2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine results in decreased activity of NOTCH1 protein] which affects the expression of ACTA2 protein | affects expression|decreases activity | 20348013
|
C028145 |
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine |
[2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine results in decreased activity of NOTCH1 protein] which affects the expression of CDH1 protein | affects expression|decreases activity | 20348013
|
C028145 |
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine |
[2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine results in decreased activity of NOTCH1 protein] which affects the expression of MMP2 protein | affects expression|decreases activity | 20348013
|
C028145 |
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine |
[2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine results in decreased activity of NOTCH1 protein] which affects the expression of MMP9 protein | affects expression|decreases activity | 20348013
|
C028145 |
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine |
[2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine results in decreased activity of NOTCH1 protein] which affects the expression of SNAI1 protein | affects expression|decreases activity | 20348013
|
C023035 |
3,4,5,3',4'-pentachlorobiphenyl |
3,4,5,3',4'-pentachlorobiphenyl results in increased expression of NOTCH1 mRNA | increases expression | 18042819
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NOTCH1 mRNA | affects expression | 16483693
|
C015001 |
arsenite |
arsenite results in decreased expression of NOTCH1 protein modified form | decreases expression | 18633435
|
C015001 |
arsenite |
tyrphostin AG 1478 inhibits the reaction [arsenite results in decreased expression of NOTCH1 protein modified form] | decreases expression|decreases reaction | 18633435
|
C006680 |
baicalein |
baicalein results in increased activity of NOTCH1 protein | increases activity | 19160421
|
C006680 |
baicalein |
baicalein results in increased expression of NOTCH1 mRNA | increases expression | 19160421
|
C038044 |
baicalin |
baicalin results in increased activity of NOTCH1 protein | increases activity | 19160421
|
C038044 |
baicalin |
baicalin results in increased expression of NOTCH1 mRNA | increases expression | 19160421
|
D002101 |
Cacodylic Acid |
Cacodylic Acid affects the expression of NOTCH1 mRNA | affects expression | 17720352
|
D002392 |
Catechin |
Catechin results in increased expression of NOTCH1 mRNA | increases expression | 15465739
|
D003474 |
Curcumin |
[Curcumin co-treated with Isoflavones] results in decreased expression of NOTCH1 protein | affects cotreatment|decreases expression | 18640131
|
D003474 |
Curcumin |
Curcumin results in decreased expression of NOTCH1 mRNA | decreases expression | 17927689
|
D003474 |
Curcumin |
Curcumin results in decreased expression of NOTCH1 protein | decreases expression | 18640131
|
D003474 |
Curcumin |
Curcumin results in decreased expression of NOTCH1 | decreases expression | 18462866
|
D016047 |
Zalcitabine |
Zalcitabine results in increased mutagenesis of NOTCH1 gene | increases mutagenesis | 18798262
|
C014347 |
decitabine |
[decitabine co-treated with trichostatin A] results in decreased expression of NOTCH1 mRNA | affects cotreatment|decreases expression | 17185465
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of NOTCH1 mRNA | increases expression | 17854601
|
D004052 |
Diethylnitrosamine |
RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of NOTCH1 mRNA] | decreases reaction|increases expression | 17854601
|
D004958 |
Estradiol |
Estradiol promotes the reaction [NOTCH1 protein binds to CCND1 promoter] | affects binding|increases reaction | 19838210
|
D004958 |
Estradiol |
Estradiol affects the expression of NOTCH1 mRNA | affects expression | 15598610
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOTCH1 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of NOTCH1 mRNA | decreases expression | 17557909
|
D007529 |
Isoflavones |
[Curcumin co-treated with Isoflavones] results in decreased expression of NOTCH1 protein | affects cotreatment|decreases expression | 18640131
|
D007529 |
Isoflavones |
Isoflavones results in decreased expression of NOTCH1 protein | decreases expression | 18640131
|
D009534 |
Niclosamide |
Niclosamide results in decreased activity of NOTCH1 protein | decreases activity | 19160421
|
C419410 |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester |
N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester results in decreased expression of NOTCH1 protein modified form | decreases expression | 18633435
|
C030110 |
oxaliplatin |
NOTCH1 protein affects the susceptibility to oxaliplatin | affects response to substance | 19147571
|
C030110 |
oxaliplatin |
oxaliplatin results in increased expression of NOTCH1 protein modified form | increases expression | 19147571
|
C030110 |
oxaliplatin |
Sulfonamides inhibits the reaction [oxaliplatin results in increased expression of NOTCH1 protein modified form] | decreases reaction|increases expression | 19147571
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of NOTCH1 mRNA | increases expression | 18301758
|
C059514 |
resveratrol |
resveratrol results in decreased expression of NOTCH1 protein | decreases expression | 17868649
|
C009166 |
retinol acetate |
retinol acetate results in increased expression of NOTCH1 mRNA | increases expression | 16772331
|
C017947 |
sodium arsenite |
sodium arsenite affects the expression of NOTCH1 mRNA | affects expression | 20056578
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of NOTCH1 mRNA | increases expression | 17879257
|
D013449 |
Sulfonamides |
Sulfonamides inhibits the reaction [oxaliplatin results in increased expression of NOTCH1 protein modified form] | decreases reaction|increases expression | 19147571
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NOTCH1 mRNA | decreases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NOTCH1 mRNA | increases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of NOTCH1 mRNA | affects expression | 18343893
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of NOTCH1 mRNA | affects binding|increases expression | 16214954
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOTCH1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin inhibits the reaction [EGF protein results in increased expression of NOTCH1 mRNA] | decreases reaction|increases expression | 15667827
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NOTCH1 mRNA | decreases expression | 17586704
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NOTCH1 mRNA | increases expression | 16611356 15800033 18796159 16960034 15328365 19684285
|
C012589 |
trichostatin A |
[decitabine co-treated with trichostatin A] results in decreased expression of NOTCH1 mRNA | affects cotreatment|decreases expression | 17185465
|
C030665 |
triphenyltin |
triphenyltin results in decreased expression of NOTCH1 mRNA | decreases expression | 12788061
|
C101044 |
tyrphostin AG 1478 |
tyrphostin AG 1478 inhibits the reaction [arsenite results in decreased expression of NOTCH1 protein modified form] | decreases expression|decreases reaction | 18633435
|
C101044 |
tyrphostin AG 1478 |
tyrphostin AG 1478 results in increased expression of NOTCH1 protein modified form | increases expression | 18633435
|
C025643 |
vinclozolin |
vinclozolin affects the expression of NOTCH1 mRNA | affects expression | 19015723
|
D002762 |
Cholecalciferol |
Cholecalciferol results in increased expression of NOTCH1 mRNA | increases expression | 17170073
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.57 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.28 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.66 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.60 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.86 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
3.97 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
3.97 | 14692618 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
6.34 | 10737359 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.34 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
3,4,5,3',4'-pentachlorobiphenyl |
22.61 | 16628245 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
22.61 | 19061943 18056438 19052882 17162532 17620307 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
22.61 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
22.61 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.42 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.62 | 16712894 17306315 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.80 | 17887948 |
MESH:D000505 |
Alopecia |
|
Isoflavones |
4.50 | 17569567 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
4.22 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
4.22 | 16183991 16162502 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.71 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.42 | 19015723 |
OMIM:109730 |
AORTIC VALVE DISEASE |
marker/mechanism |
|
| |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.19 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.79 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.79 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
2.67 | 16807698 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
6.37 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.37 | 16873680 17967414 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
10.18 | 16142846 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
10.18 | 19761891 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.94 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.94 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.51 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.59 | 15746008 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
9.39 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
9.39 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
3.70 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
|
Cacodylic Acid |
3.58 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
3.58 | 19250217 18462866 18593918 16243823 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
3.58 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
3.58 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.58 | 12948864 18497071 17289903 19861407 14630087 16675129 17261762 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
3.58 | 17651959 17534123 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.58 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
tyrphostin AG 1478 |
4.67 | 12794006 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.18 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
7.56 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.56 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.21 | 19208518 20432363 18788625 19418558 17162532 16779866 19052882 19519916 17138121 19701751 20512989 16288022 20514400 18691550 17055752 16681979 16328049 20084675 16540662 19335982 16830150 19394651 19919837 19822196 18494052 3581430 16878318 18056438 19171122 18978308 19383236 18971187 20214788 20524982 20101231 16807293 19107877 18506893 18210153 17173139 16935385 20007298 10672840 18785209 18393292 11831363 17978847 10737359 16569478 17428255 20727157 20935162 3084413 18665156 16502159 21159647 16698587 17761372 19539802 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
6.21 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
6.21 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
6.21 | 15276417 17306315 16507464 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.31 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
2.88 | 18414057 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
10.14 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
10.14 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
10.14 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
10.14 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.21 | 18850075 16120746 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Zalcitabine |
4.53 | 10591146 |
MESH:D002318 |
Cardiovascular Diseases |
|
Isoflavones |
7.19 | 17689850 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
7.19 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
10.11 | 17174075 7505956 21159647 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.11 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
10.11 | 19524636 20056578 |
MESH:D018281 |
Cholangiocarcinoma |
|
3,4,5,3',4'-pentachlorobiphenyl |
14.87 | 16628245 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
14.87 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
14.87 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.06 | 17333356 16919318 17110522 15861022 11677210 16105132 17681005 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.06 | 19176532 |
MESH:D016770 |
Ciliophora Infections |
|
Niclosamide |
5.45 | 12113305 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.99 | 12621046 15668235 16354765 15340226 8697196 |
MESH:D003092 |
Colitis |
|
Curcumin |
8.89 | 18200517 16804969 16782535 |
MESH:D003092 |
Colitis |
|
resveratrol |
8.89 | 16474422 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.30 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
marker/mechanism |
|
| 19147571 |
MESH:D003110 |
Colonic Neoplasms |
|
arsenite |
10.52 | 15037631 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
10.52 | 16340194 19359593 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
10.52 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
oxaliplatin |
10.52 | 16024531 16004971 16510598 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
10.52 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
4.68 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Isoflavones |
4.68 | 17116718 |
MESH:D015179 |
Colorectal Neoplasms |
|
oxaliplatin |
4.68 | 17401013 18509181 17695437 17255274 17594712 18448328 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
4.68 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
marker/mechanism |
|
| 17849441 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.83 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.62 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.57 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 17849441 |
MESH:D019465 |
Craniofacial Abnormalities |
|
3,4,5,3',4'-pentachlorobiphenyl |
2.83 | 17686920 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.83 | 15322242 20055451 10048152 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.07 | 14966744 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.30 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.55 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
6.70 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
6.70 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.70 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
13.75 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.75 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
13.75 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
3.45 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.45 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.87 | 11462148 |
MESH:D004362 |
Drug Toxicity |
|
Zalcitabine |
7.87 | 7515130 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.78 | 17351913 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.00 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
10.00 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.00 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
3,4,5,3',4'-pentachlorobiphenyl |
11.47 | 17686920 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.47 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.24 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
8.24 | 17872969 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
13.08 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
13.08 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.80 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.78 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.57 | 17923197 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
4.83 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenite |
27.48 | 18296743 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
27.48 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
27.48 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
27.48 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
27.48 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Zalcitabine |
27.48 | 18299183 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.18 | 11858732 |
MESH:D005355 |
Fibrosis |
|
arsenite |
24.91 | 18296743 |
MESH:D005355 |
Fibrosis |
|
baicalein |
24.91 | 19474275 |
MESH:D005355 |
Fibrosis |
|
baicalin |
24.91 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
24.91 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
24.91 | 20067830 |
MESH:D005393 |
Fish Diseases |
|
Niclosamide |
5.41 | 12113305 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.42 | 18462866 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.65 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.02 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.40 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
baicalein |
11.23 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
11.23 | 17596214 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
11.23 | 18801729 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.31 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
7.38 | 18829502 18462866 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.38 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
2,3,7,8-tetrachlorodibenzofuran |
10.61 | 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
3,4,5,3',4'-pentachlorobiphenyl |
10.61 | 20471113 17686920 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.61 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.37 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.09 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.35 | 19176532 19772884 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.35 | 15340226 16120746 12621046 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.77 | 17701891 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.75 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.90 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Zalcitabine |
4.19 | 17457083 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.93 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
9.48 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Isoflavones |
9.48 | 17290160 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.76 | 16354765 16959395 8697196 15340226 18606429 |
MESH:D006930 |
Hyperalgesia |
|
oxaliplatin |
4.14 | 17418472 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
8.56 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
8.56 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
9.04 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
triphenyltin |
9.04 | 10522495 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Catechin |
4.74 | 17292331 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.77 | 16873680 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.80 | 18850075 18670907 |
MESH:D015228 |
Hypertriglyceridemia |
|
triphenyltin |
5.71 | 10522495 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.06 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.54 | 16569931 16945680 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.37 | 17600658 |
MESH:D007246 |
Infertility |
|
triphenyltin |
5.76 | 15205045 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.20 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
14.53 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
14.53 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
14.53 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
14.53 | 16467254 |
MESH:D007249 |
Inflammation |
|
Curcumin |
10.78 | 18403477 17151092 16956363 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
10.78 | 18785209 |
MESH:D007249 |
Inflammation |
|
resveratrol |
10.78 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.78 | 12878042 12200463 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
3.10 | 18596194 18200517 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.26 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.59 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
6.59 | 16306350 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.98 | 10783313 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.57 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.57 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
2.76 | 15610895 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
4.31 | 18555241 |
MESH:D007938 |
Leukemia |
|
Curcumin |
6.14 | 18462866 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.14 | 19235587 18980019 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
3.96 | 16106398 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
3.75 | 19117987 18454857 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.09 | 18206229 17679729 18704418 18460780 19387464 19010910 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
4.09 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.18 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.40 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
4.50 | 16106398 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.45 | 16417039 |
MESH:D008103 |
Liver Cirrhosis |
|
arsenite |
6.32 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.32 | 19638242 20032147 18407596 18665156 18522880 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
baicalin |
6.37 | 18187930 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
6.37 | 18006644 18705752 17355460 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.37 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
6.37 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.37 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
6.45 | 16956363 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.45 | 17034775 |
MESH:D008107 |
Liver Diseases |
|
Sulfonamides |
6.45 | 14986274 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
13.07 | 19090486 18648771 21278145 12771043 20405173 12112319 20492335 20101389 19499222 20583210 10737359 18644402 19638242 15885732 19073162 15175105 19551842 18754104 2862719 19850985 21047994 19254457 21071580 20434301 21167192 20452335 16942905 19255062 2422723 19690152 19427195 20137499 20501860 19812893 9163691 18977376 19833225 19996281 19642983 19294768 19256749 20118626 18978307 19426721 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
13.07 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
13.07 | 19812893 19073162 19321006 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.07 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.07 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
5.19 | 18093689 19009564 16842330 18775883 2563599 17854601 19004024 18079962 9362446 19539802 17942915 21159647 3124819 18544905 18308698 16267830 19519916 18282651 18253720 19126423 17174075 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.19 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.99 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
arsenite |
6.21 | 16809336 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
6.21 | 18462866 19359593 16243823 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
6.21 | 20512841 20970405 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.21 | 16712894 17306315 17077188 15276417 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.21 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
marker/mechanism |
|
| 18798262 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
11.67 | 18462866 |
MESH:D008223 |
Lymphoma |
|
decitabine |
11.67 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Zalcitabine |
11.67 | 11980663 17941976 9488045 18798262 9205081 8840982 8764131 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.04 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.65 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.42 | 16173963 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.97 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.56 | 17203775 11408345 16891317 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
5.56 | 11606380 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.20 | 19453300 |
MESH:D008545 |
Melanoma |
|
Curcumin |
9.24 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
decitabine |
9.24 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
resveratrol |
9.24 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.24 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
9.24 | 16505122 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.89 | 17263510 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.13 | 17112576 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
15.72 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
15.72 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
15.72 | 17049120 17935668 16490592 14749477 16267019 17164350 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
15.72 | 18172295 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
11.48 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
11.48 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.23 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.22 | 19157545 18608210 19010910 16882708 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.35 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.35 | 17188708 16456233 16525036 17125593 16317513 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.28 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.28 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.55 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.55 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.48 | 17322642 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
4.10 | 18495463 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.46 | 3581430 9029167 |
MESH:D009369 |
Neoplasms |
|
decitabine |
7.47 | 19470736 19116145 17925555 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.47 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
7.47 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
13.91 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
13.91 | 20056578 |
MESH:D009374 |
Neoplasms, Experimental |
|
Zalcitabine |
13.91 | 8764131 9205081 9488045 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
4.25 | 12497104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
arsenite |
9.22 | 15738583 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
9.22 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
8.58 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.58 | 14600291 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.35 | 18462866 |
MESH:D009437 |
Neuralgia |
|
Zalcitabine |
6.04 | 17292584 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
2.96 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
7.78 | 20387270 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.78 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.14 | 17929310 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
4.83 | 20387270 |
MESH:D009765 |
Obesity |
|
Curcumin |
4.36 | 19297423 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.36 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
7.10 | 18719352 |
MESH:D010024 |
Osteoporosis |
|
Isoflavones |
7.10 | 16562857 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.00 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
14.02 | 19020741 18462866 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
14.02 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
14.02 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
14.02 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
14.02 | 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
11.55 | 17440100 19196508 19401701 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
11.55 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
11.55 | 16540662 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
11.55 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.43 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.96 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Zalcitabine |
5.04 | 18606552 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.29 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.32 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
14.66 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.66 | 11222880 11896295 11399792 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
14.66 | 19015723 18042343 18220299 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
11.51 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
11.51 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.65 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.63 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
baicalin |
2.39 | 15714805 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
2.39 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
2.39 | 11398177 15129424 18226269 12497104 18156803 18769126 10851300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.39 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Isoflavones |
2.39 | 16365062 17571952 17219775 17374662 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.39 | 15767336 17636462 17804756 17718901 17675339 16731767 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.39 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.39 | 19789329 18798265 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.65 | 18629315 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.03 | 16919318 15861022 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.28 | 19168576 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.30 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.11 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.11 | 16317513 16314181 17520802 17058453 15827377 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
3.77 | 10666014 18379247 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.57 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.14 | 19155313 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.88 | 18462866 |
MESH:D012600 |
Scoliosis |
marker/mechanism |
|
| 17849441 |
MESH:D012640 |
Seizures |
|
Sulfonamides |
4.64 | 20420384 |
MESH:D018805 |
Sepsis |
|
Curcumin |
3.85 | 18389075 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
8.71 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
8.71 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
8.71 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.66 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.58 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.46 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
2.46 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
3.26 | 16631530 19188055 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.24 | 16321402 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.36 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.92 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.62 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
6.59 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
6.59 | 7505956 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.40 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.97 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cacodylic Acid |
11.11 | 15537745 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
11.11 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
11.11 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.11 | 16712894 17306315 11723127 16452187 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.98 | 18462866 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
8.76 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.76 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.61 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
8.61 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.63 | 17785578 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.14 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.31 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.29 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.03 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.96 | 15886252 |